Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple viral and host nucleotide-dependent processes refers to a collective set of biochemical pathways and enzymes involved in the metabolism and polymerization of nucleotides, which are essential for both cellular function and viral replication. This is not a single molecular target but rather a functional category often used to describe the broad-spectrum mechanism of action of drugs like Ribavirin (Graci & Cameron, 2006). The processes involved include host-side enzymes such as Inosine Monophosphate Dehydrogenase (IMPDH), which regulates the guanosine triphosphate (GTP) pool, and viral-side enzymes like RNA-dependent RNA polymerase (RdRp) (Thomas et al., 2011). By disrupting these multiple processes, therapeutic agents can inhibit viral RNA capping, suppress genome replication, and induce lethal mutagenesis, where the viral mutation rate is increased beyond a sustainable threshold (Crotty et al., 2000). While this multi-target approach is effective against a wide range of RNA viruses and reduces the likelihood of resistance, it often results in a narrow therapeutic index due to the essential nature of nucleotide metabolism in healthy host cells. Consequently, drugs targeting these processes are frequently associated with significant systemic toxicities, most notably hemolytic anemia (FDA Label, Rebetol).
Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH) to deplete GTP pools, inhibition of viral RNA-dependent RNA polymerase (RdRp), interference with viral mRNA capping, and induction of lethal mutagenesis in viral genomes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple viral and host nucleotide-dependent processes.